But these conversations now include more nuance than they did a year ago, especially when perimenopause, sleep apnea, or prediabetes are also in the picture
While the votes are significant, important regulatory and compliance questions remain
E., Ravuri, C., and Moens, U
Additional Safety Information: Not recommended for individuals who are pregnant, breastfeeding, or planning to become pregnant or breastfeed
Program Overview: GLP Elite, RM3, and DirectMed RMWL offers three core weight loss programs: GLP Elite: This program incorporates GLP-1 agonist medications (like semaglutide or tirzepatide medications that help regulate appetite and improve insulin sensitivity)
*Correspondence: Xian-Feng Zhang, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers